SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?


To: SSP who wrote (73470)12/6/2000 10:40:41 AM
From: SSP  Respond to of 150070
 
yesterday's news - Century Milestone's Board Approves 5-Year Plan


Business Editors

BEIJING--(BUSINESS WIRE)--Dec. 5, 2000--Century Milestone S&T Co.
(OTCBB:CEML) directors recently reviewed and approved the first 5-Year
Plan developed since the company was listed.
The Plan identifies the following markets for the company,
designed to produce revenues of $50 million within 48 months:
CCTV monitoring, multi-channel DVRs, decoders, data storage and
management units for local or remote server-feeds, real-time video
transmission software for copper, PSTN, DDN/ISDN, and IP based
networks, high-resolution videophone software for fixed-line or
wireless phones and appliances.
In addition the company will manufacture DVRs and videophones with
its own embedded compression algorithms based on new CMOS chips.
The company will continue its policy of alliances with world
equipment brands, where it can be a national distributor and
subsequently a full manufacturing partner, as well as launching its
own products. Century Milestone plans to become itself a world brand
by 2003 after developing a strong national sales coverage during 2001
and regional coverage during 2002.
The company has started a program to further protect its know-how
via international patents and copyrights. It is also participating in
international committees to define video transmission and videophone
standards.
Century Milestone S & T Co. (Symbol: CEML) is an established young
company with talented management in the growing Chinese market for
large-scale closed-circuit TV installations (CCTV), particularly for
security surveillance and remote industrial monitoring. The company
handles the whole chain through site installation, image capture,
compression, transmission, storage and retrieval. Its clients are
government agencies and corporations. The company is a national leader
in this field. The company draws its unique positioning from its
world-class mathematicians who have developed most efficient
compression algorithms. CEML's compression know-how has allowed it to
become a developer of hard-disk based digital video recorders (DVR's)
which will produce license revenue from electronics companies in the
near future. The algorithms allow the software in the DVR's to store
unprecedented amounts of data that can be manipulated by computer
instead of the old tape-libraries. This compression and storage
know-how is opening new markets for the company in pure data-storage
and videophonics.

Website: cms.com.cn or
via centurymilestone.com

SEC filings, including quarterly financials, business
description, personnel:
freeedgar.com
ompanyList&CIK=799070&UseFrame=1&FormType=&DateFiled=&CompanyNa
me=CENTURY+MILESTONE+S%26T+CO+LTD

Business-TV interview: broadcast.com
BTV#55 starts at 11.30 minute point.

NOTE ON FORWARD-LOOKING STATEMENTS: Statements herein contained
that are not strictly historical are "forward-looking" statements
within the meaning of Section 27A of the Securities Act of 1998 as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These forward-looking statements are made based upon
information available as of the date hereof, and the company assumes
no obligation to update such forward-looking statements. Editors and
investors are cautioned that such forward-looking statements involve
risk and uncertainties and the company's actual results may differ
from these forward-looking statements. Such risks and uncertainties
include but are not limited to demand for the company's products and
services, the company's ability to continue to develop its market,
general economic conditions and other factors that may be more fully
described in reports to shareholders and periodic filings with the
Securities and Exchange Commission.

--30--jlm/in*

CONTACT: Century Milestone S&T Co.
Michael Harrop
Tel: 41 22 9000000
Fax: 41 22 9000002
mail@harrop.com



To: SSP who wrote (73470)12/6/2000 10:48:37 AM
From: Jim Bishop  Read Replies (1) | Respond to of 150070
 
United Therapeutics Announces Stock Repurchase Program
SILVER SPRING, Md., Dec. 5 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR - news) announced today that its Board of Directors approved a stock repurchase program of up to 3,000,000 shares of its outstanding stock over the next six months.

It is anticipated that these purchases will be made at management's discretion in the open market and/or through privately negotiated transactions, subject to market conditions. United Therapeutics further announced that some members of its Board of Directors and senior management also plan to make market purchases of the company's stock. There are approximately 20,185,000 shares of United Therapeutics common stock outstanding.

``Our board of directors and management believe that United Therapeutics' stock is substantially undervalued by the market and we decided to take advantage of this opportunity to capture some of this value for our continuing shareholders,'' said Martine Rothblatt, Chairman and CEO of United Therapeutics. ``With approximately $230 million in cash, cash equivalents and investments, our financial position is sufficiently strong to allow for both this stock repurchase and our continued drug development program. The board's decision to initiate a stock repurchase program underscores our belief that United Therapeutics' shares are substantially undervalued and demonstrates our commitment to enhance shareholder value.''

United Therapeutics is a biotechnology company focused on combating cardiovascular, inflammatory and infectious diseases with unique therapeutic products.

SOURCE: United Therapeutics Corporation